Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-10-24
1998-01-20
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514262, 514291, 514297, 514316, 514318, 514320, 514322, 514323, 514326, 514331, 544310, 544405, 546 90, 546102, 546188, 546189, 546194, 546196, 546199, 546200, 546201, 546207, 546208, 546210, 546211, 546213, 546214, 546217, 546234, A61K 31445, C07D21152
Patent
active
057101698
ABSTRACT:
Compounds of formula I ##STR1## wherein Q.sup.1, Q.sup.2, Q.sup.3, Q.sup.4, and Q.sup.5 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of SP and NKA are useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
REFERENCES:
patent: 3518274 (1970-06-01), Strycker
patent: 3862946 (1975-01-01), Havers
patent: 3906100 (1975-09-01), Havera
patent: 4782061 (1988-11-01), Kruse et al.
patent: 4962113 (1990-10-01), Tsushima et al.
patent: 5236921 (1993-08-01), Emonds-Alt et al.
Maggi, C.A. et al, American Review of Respiratory Disease, 1991(Aug.), 144(2), pp. 363-367, abstract only.
A. Graham et al., "Isolation and Characterization of the Human Lung NK-2 Receptor Gene Using Rapid Amplification of cDNA Ends", Biochemical and Biophysical Research Communications, (1991), vol. 177, No. 1, 0-16.
X. Emonds-Alt et al., "Pharmacological Profile and Chemical Synthesis of SR 48968, a Non-Peptide Antagonist of the Neurokinin A (NK2) Receptor", Biorganic & Medicinal Chemistry Letters, (1993), vol. 3, No. 5, 925-930.
D. Anarony et al., "Pharmacologic Characterization of the Novel Ligand Bladder Membranec", Neuropeptidec, (1992), 23, 121-130.
M. Needham et al., "LCR/MEL: A Versatile System for High-Level Expression of Heterologous Proteins in Erythroid Cells", Nucleic Acids Research, (1992), vol. 20, No. 5, 997-1003.
O. E. Fancher et al., "New Analgesic N-Substituted Carboxamides", Analgenic N-Substituted Carboxomides, (1964), 721-725.
Dahlen Garth M.
Darkes Paul R.
Harris Robert J.
Ivy C. Warren
Zeneca Limited
LandOfFree
Therapeutic heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic heterocycles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-725716